Prosperity Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.89M Sell
11,474
-72
-0.6% -$15.5K 0.89% 37
2026
Q1
$2.51M Buy
11,546
+7,094
+159% +$1.57M 0.93% 33
2025
Q4
$1.02M Sell
4,452
-88
-2% -$20K 0.37% 67
2025
Q3
$1.05M Buy
4,540
+20
+0.4% +$4.07K 0.38% 70
2025
Q2
$839K Sell
4,520
-115
-2% -$21.4K 0.36% 71
2025
Q1
$971K Buy
4,635
+27
+0.6% +$5.25K 0.48% 56
2024
Q4
$819K Buy
4,608
+28
+0.6% +$5.15K 0.41% 62
2024
Q3
$904K Buy
4,580
+56
+1% +$10.5K 0.51% 51
2024
Q2
$776K Sell
4,524
-488
-10% -$80.8K 0.49% 55
2024
Q1
$913K Buy
5,012
+571
+13% +$98.4K 0.56% 48
2023
Q4
$688K Buy
4,441
+67
+2% +$9.77K 0.48% 47
2023
Q3
$652K Sell
4,374
-15
-0.3% -$2.2K 0.54% 44
2023
Q2
$591K Buy
4,389
+42
+1% +$6.16K 0.52% 47
2023
Q1
$693K Sell
4,347
-82
-2% -$12.5K 0.7% 39
2022
Q4
$716K Buy
+4,429
New +$679K 0.77% 32

Other funds holding ABBV

Prosperity Financial Group's ABBV Position: Q2 2026 in Review

Prosperity Financial Group reduced its AbbVie (ABBV) stake by 0.62% in Q2 2026, selling an estimated $15.5K and leaving 11,474 shares worth $2.89M. The position accounts for 0.89% of the portfolio, ranked #37.

Prosperity Financial Group first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,207 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Prosperity Financial Group held 11,474 shares of AbbVie worth $2.89M as of Q2 2026.
  • Prosperity Financial Group sold 72 AbbVie shares in Q2 2026, an estimated $15.5K.
  • AbbVie made up 0.89% of Prosperity Financial Group's portfolio in Q2 2026, its #37 holding.
  • Prosperity Financial Group first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 4,207 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Prosperity Financial Group's 13F filing for Q2 2026, filed 28 Jul 2026.